Inabata & Co., Ltd.

Embedded Flash Memory Developer Floadia Raises 1.05 Billion Yen from Inabata and Others

Retrieved on: 
Wednesday, October 11, 2023
Inabata & Co., Ltd., UMC, Faraday Technology, AI, Japan Finance Corporation, Intellectual property, TSMC, Electronics, Temperature, G1, CIM, INCJ, Venture round, Computer data storage, Memory

TOKYO, Oct. 11, 2023 /PRNewswire/ -- Floadia Corporation (hereinafter referred to as "Floadia"), which develops embedded flash memory IP cores based in the Tokyo suburb of Kodaira-shi, has raised approximately 1.05 billion yen in Series D round.

Key Points: 
  • TOKYO, Oct. 11, 2023 /PRNewswire/ -- Floadia Corporation (hereinafter referred to as "Floadia"), which develops embedded flash memory IP cores based in the Tokyo suburb of Kodaira-shi, has raised approximately 1.05 billion yen in Series D round.
  • Floadia will use the funds raised to strengthen sales activities promoting its current primary business, embedded flash memory IP cores, to semiconductor manufacturers, and to enhance developing ultra-low power consumption AI accelerator chips that utilize flash memory devices.
  • Floadia is developing Computing in Memory (CIM) chips, which use flash memory devices as information transmission media, as a pillar of the next business following flash memory IP cores.
  • Floadia's flash memory solves these issues with analog memory technology and enables advanced AI inference calculations in edge environments with significantly low power consumption.

EQS-News: Enapter AG supports Tokyo Gas in implementing Japan’s hydrogen strategy transition

Retrieved on: 
Wednesday, July 19, 2023
Hydrogen, AEM, Inabata & Co., Ltd., Electrolysis, Electrolysed water, Tokyo Gas, Investment, Natural gas, ISIN, DRY, Coal

Enapter supplies 30 AEM Electrolysers EL 2.1 to Tokyo Gas, Japan’s largest natural gas utility and one of Asia's largest energy suppliers.

Key Points: 
  • Enapter supplies 30 AEM Electrolysers EL 2.1 to Tokyo Gas, Japan’s largest natural gas utility and one of Asia's largest energy suppliers.
  • With Enapter’s devices, Tokyo Gas produces hydrogen for Asia’s first commercial hydrogen refueling station that uses AEM electrolysis.
  • Berlin (19 July 2023); Enapter AG (ISIN:DE000A255G02) has delivered 30 AEM EL 2.1 electrolysers and 15 DRY 2.1 dryers for a hydrogen refuelling station in Tokyo, Japan, as part of a cooperation with the Japanese gas company Tokyo Gas.
  • Beyond the current project, it is planned to explore the potential use of hydrogen together with Tokyo Gas and to implement further hydrogen projects in Japan.

Otsuka and Lundbeck Announce U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application (sNDA) for REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer’s Disease

Retrieved on: 
Thursday, May 11, 2023
Mental Health, Research, FDA, Neurology, Genetics, Health, Pharmaceutical, General Health, Science, CMAI, Week, New Drug Application, Medication, Agitation, Incidence, Shanda, Dementia, Patient, Inabata & Co., Ltd., Otsuka Pharmaceutical, Diagnosis, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Brexpiprazole, Food, Caregiver, Safety, Residential care, Lundbeck

Otsuka Pharmaceutical, Co. Ltd. (Otsuka) and Lundbeck LLC (Lundbeck) announce the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) of REXULTI® (brexpiprazole) for use in the treatment of agitation associated with dementia due to Alzheimer’s disease.

Key Points: 
  • Otsuka Pharmaceutical, Co. Ltd. (Otsuka) and Lundbeck LLC (Lundbeck) announce the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) of REXULTI® (brexpiprazole) for use in the treatment of agitation associated with dementia due to Alzheimer’s disease.
  • This approval makes REXULTI the first and only pharmacological treatment approved in the U.S. for agitation associated with dementia due to Alzheimer’s disease.
  • Agitation is a common neuropsychiatric symptom in Alzheimer’s dementia and one of the most complex and stressful aspects of caring for people living with the condition.
  • Brexpiprazole patients with agitation associated with dementia due to Alzheimer’s disease achieved a 31% greater reduction from baseline in frequency of agitation symptoms vs. placebo.

The Global Circuit Breaker Market is expected to grow by $ 2.58 bn during 2022-2026, accelerating at a CAGR of 5.42% during the forecast period

Retrieved on: 
Wednesday, November 16, 2022
ABB, Shanghai Huayi (Group) Company, CG Power and Industrial Solutions, Fonar Corp. v. General Electric Co., Industry, LS, Inabata & Co., Ltd., Schneider Electric, Research, Connected space, Adoption, Wind, TE, Siemens, Mitsubishi Electric, Retail

View original content:https://www.prnewswire.com/news-releases/the-global-circuit-breaker-mark...

Key Points: 
  • Also, emergence of smart grids and increase in offshore wind farm installations will lead to sizable demand in the market.
  • The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
  • The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Hotel M's Co. Ltd in Kyoto chooses Sabre technology to drive inbound tourism as Japan prepares to relax travel restrictions for international visitors

Retrieved on: 
Wednesday, July 13, 2022
Technology, Hospitality, SABR, NASDAQ, Solution, Sabre Corporation, Walking, Travel, Tourism, Global distribution system, Inabata & Co., Ltd., Kyōto Station, Software, Sabre, Hotel, Teahouse

SOUTHLAKE, Texas, and SINGAPORE and KYOTO, Japan, July 13, 2022 /PRNewswire/ -- Sabre Corporation (NASDAQ: SABR), a leading software and technology provider that powers the global travel industry, today announced a new agreement with Hotel M's Co. Ltd in Kyoto, Japan, to help the chain to grow geographic reach and attract international travelers as Japan eases border restrictions.

Key Points: 
  • Japan has been steadily relaxing travel restrictions since March ahead of a wider-scale re-opening to foreign visitors.
  • To prepare for, and capture, the expected influx of tourism, Hotel M's Co. Ltd has inked a new technology agreement with Sabre.
  • With 1,274 hotel rooms currently, the chain has selected Sabre technology to help advance its expansion strategy and revenue growth.
  • As a hotel born and raised in Kyoto, we value regional connections and are working to revitalize the entire city of Kyoto.

Global Biodegradable Mulch Film Market to Reach $83.6 Million by 2026

Retrieved on: 
Monday, April 18, 2022
Atmosphere, Farmer, Population, COVID-19, Research, CAGR, Biopolymer, Nutrient, BASF, Players, Agriculture, SE, Fertilizer, Forecasting, Health, Water, Adoption, Vegetable, Plant, Pesticide, PHA, RKW, Gardening, Starch, Nature, Carbon, Flower, Marketing, Sugar, Germination, Geography, PLA, Efficiency, Others, Temperature, BASF SE, Horticulture, Erosion, Inabata & Co., Ltd., Intelligence, Fertility, SAN, GIA, Maintenance, Herbicide, Internet, Fruit, Soil

SAN FRANCISCO, April 18, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Biodegradable Mulch Film - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, April 18, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Biodegradable Mulch Film - Global Market Trajectory & Analytics" .
  • Biodegradable mulch varies from plastic mulch in the fact that the form is not removed from the field once the season comes to an end, as the biodegradable mulch breaks down due to heat.
  • Amid the COVID-19 crisis, the global market for Biodegradable Mulch Film estimated at US$62.7 Million in the year 2022, is projected to reach a revised size of US$83.6 Million by 2026, registering a compounded annual growth rate (CAGR) of 7.6 % over the analysis period.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Global Biodegradable Mulch Film Market to Reach $83.6 Million by 2026

Retrieved on: 
Monday, April 18, 2022
Atmosphere, Farmer, Population, COVID-19, Research, CAGR, Biopolymer, Nutrient, BASF, Players, Agriculture, SE, Fertilizer, Forecasting, Health, Water, Adoption, Vegetable, Plant, Pesticide, PHA, RKW, Gardening, Starch, Nature, Carbon, Flower, Marketing, Sugar, Germination, Geography, PLA, Efficiency, Others, Temperature, BASF SE, Horticulture, Erosion, Inabata & Co., Ltd., Intelligence, Fertility, SAN, GIA, Maintenance, Herbicide, Internet, Fruit, Soil

SAN FRANCISCO, April 18, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Biodegradable Mulch Film - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, April 18, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Biodegradable Mulch Film - Global Market Trajectory & Analytics" .
  • Biodegradable mulch varies from plastic mulch in the fact that the form is not removed from the field once the season comes to an end, as the biodegradable mulch breaks down due to heat.
  • Amid the COVID-19 crisis, the global market for Biodegradable Mulch Film estimated at US$62.7 Million in the year 2022, is projected to reach a revised size of US$83.6 Million by 2026, registering a compounded annual growth rate (CAGR) of 7.6 % over the analysis period.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Global Bioplastics and Biopolymers Market to Reach $17.1 Billion by 2025

Retrieved on: 
Monday, March 28, 2022
CAGR, Organization, Players, Polymer, BASF SE, Marketing, SE, Inabata & Co., Ltd., Growth, Internet, NatureWorks, Plastic, Certification, Research, Forecasting, Environment, Soil, Health, Intelligence, Carbon, BASF, Government, Technology, Others, GIA, Mitsubishi Chemical Corporation, Tax, COVID-19, Attention, BIOTEC, Awareness, Nature, SAN, Toxicity, Recycling, Biopolymer, Bioplastic

SAN FRANCISCO, March 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Bioplastics and Biopolymers - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, March 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Bioplastics and Biopolymers - Global Market Trajectory & Analytics" .
  • Amid the COVID-19 crisis, the global market for Bioplastics and Biopolymers estimated at US$11.3 Billion in the year 2022, is projected to reach a revised size of US$17.1 Billion by 2025, registering a compounded annual growth rate (CAGR) of 15.6% over the analysis period.
  • Europe represents the largest regional market for Bioplastics and Biopolymers, accounting for an estimated 35.2% share of the global total.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Chubu Electric Power and a Consortium of Investors Acquire 52.7 MWp Biomass Project From Solariant Capital

Retrieved on: 
Thursday, February 10, 2022
GLOBE, Hitachi Zosen Corporation, Biomass, Chubu Electric Power, Sumitomo Mitsui Trust Holdings, Semper Solaris, Electricity, Inabata & Co., Ltd., Capital, Partnership, Project, LLC, Renewable energy

PASADENA, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Solariant Capital, LLC("Solariant"), a renewable energy investment and development company headquartered in Pasadena, California, is pleased to announce that a consortium of Japanese companies including Chubu Electric Power Co., Inc., Inabata & Co., Taihei Dengyo Co., Ltd., Tokyo Sangyo Co. Ltd., and Hitachi Zosen Corporation entered into an agreement with Solariant to acquire its 52.7 MWp biomass power plant project (the "Project").

Key Points: 
  • PASADENA, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Solariant Capital, LLC("Solariant"), a renewable energy investment and development company headquartered in Pasadena, California, is pleased to announce that a consortium of Japanese companies including Chubu Electric Power Co., Inc., Inabata & Co., Taihei Dengyo Co., Ltd., Tokyo Sangyo Co. Ltd., and Hitachi Zosen Corporation entered into an agreement with Solariant to acquire its 52.7 MWp biomass power plant project (the "Project").
  • Solariant retained a minority interest in the project company, Fukuyama Biomass Power Plant GK.
  • The Project will be constructed by Hitachi Zosen consortium (to breaking ground in 2022), and Sumitomo Mitsui Trust Bank is providing the project debt.
  • "This is the second biomass project we are working with Chubu Electric and Hitachi Zosen, and we are excited to expand our project partnership with great partners," commented Daniel Kim, Managing Director of Solariant Capital.

Curi Bio and NEXEL Announce Celogics, Joint Venture to Develop Leading iPSC-derived Cell Products

Retrieved on: 
Tuesday, October 26, 2021
Health, Stem Cells, Research, Science, Pharmaceutical, Cardiology, Biotechnology, Technology, Industry, Neuron, Drug development, Inabata & Co., Ltd., 3D, Bio, Partnership, Patient, Drug discovery, Disease, CRISPR, Muscular dystrophy, B cell, IPSC, Growth, Tissue, Multimedia, Cardiomyopathy, Cell, Therapy, Toxicity, Population, Gene editing, Philosophy, Glossary, Hepatocyte, Pharmaceutical industry, Curi Bio, NEXEL, CURI BIO, NEXEL

View the full release here: https://www.businesswire.com/news/home/20211026006164/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20211026006164/en/
    The US accounts for nearly 50% of the global stem cell market, and the Celogics joint venture partnership with market leader Curi Bio will represent a major strategic entry for Nexel into the US.
  • By providing leading global pharmaceutical companies access to human-relevant models during preclinical drug development, Curi Bio helps leading pharmaceutical companies develop safer and more effective therapeutics in less time, at lower cost.
  • As a joint venture partnership between Curi Bio and Nexel, Celogics will be extremely well-positioned to meet the large and rapidly growing market need for high-quality human iPSC-derived cell products, said Curi Bio CEO Michael Cho.
  • "Celogics is leading the global market with stem cell-derived somatic cell products for toxicity evaluation and drug discovery, said Nexel CEO Choong-seong Han.